Glipizide Tablet
Product Images NDC 51655-106

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 51655-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655 106 26 Master Bottle Label Approval Rev A 06 20

Label for Glipizide Tablets, USP 10 mg, containing 90 tablets. It indicates prescription use only and includes storage instructions to keep out of reach of children and store in original container. The label shows manufacturer as Northwind Pharmaceuticals and displays NDC 51655-106-26 along with lot, expiration date, and packaging information.*

FDA Label Image

Glipizide Structure

Chemical structure diagram of Glipizide, showing its molecular components including a pyrazine ring, benzene ring, sulfonylurea group, and cyclohexyl group, representing the active ingredient in the Glipizide 10 mg oral tablet by Northwind Health Company, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.